Section Arrow
ABOS.NASDAQ
- Acumen Pharmaceuticals
Quotes are at least 15-min delayed:2025/05/25 06:28 EDT
Last
 1.02
-0.01 (-0.97%)
Day High 
1.04 
Prev. Close
1.03 
1-M High
1.1552 
Volume 
329.60K 
Bid
0.9901
Ask
1.03
Day Low
0.9901 
Open
1.02 
1-M Low
0.9514 
Market Cap 
62.39M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.03 
20-SMA 1.04 
50-SMA 1.08 
52-W High 3.6 
52-W Low 0.8551 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.94/-1.87
Enterprise Value
90.99M
Balance Sheet
Book Value Per Share
2.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PLRZPolyrizon Ltd0.0034-0.0008-19.05%-- 
IMNNImunon1.16+0.7445+179.18%-- 
NCNANuCana plc0.038-0.0014-3.55%-- 
RXRXRecursion Pharmaceuticals4.08-0.065-1.57%-- 
KLTOKlotho Neurosciences Inc0.1923+0.0033+1.75%-- 
Quotes are at least 15-min delayed:2025/05/25 06:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.